Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Ind-Swift Laboratories Ltd. ( (IN:INDSWFTLAB) ) is now available.
Ind-Swift Laboratories Ltd. has received trading approval from both BSE Limited and the National Stock Exchange of India Limited for over 8.1 million equity shares, each valued at ₹10. This approval follows the company’s Scheme of Amalgamation, where Ind-Swift Limited was merged with Ind-Swift Laboratories Ltd. The shares will be available for trading from December 5, 2025, marking a significant step in the company’s strategic growth and market presence.
More about Ind-Swift Laboratories Ltd.
Ind-Swift Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients and finished dosage forms. The company is known for its emphasis on quality and innovation, serving a global market with a diverse product portfolio.
Average Trading Volume: 6,197
Technical Sentiment Signal: Hold
Current Market Cap: 6.83B INR
Learn more about INDSWFTLAB stock on TipRanks’ Stock Analysis page.